Bjarnsholt Thomas
Københavns Universitet, København N, Denmark.
APMIS Suppl. 2013 May(136):1-51. doi: 10.1111/apm.12099.
Acute infections caused by pathogenic bacteria have been studied extensively for well over 100 years. These infections killed millions of people in previous centuries, but they have been combated effectively by the development of modern vaccines, antibiotics and infection control measures. Most research into bacterial pathogenesis has focused on acute infections, but these diseases have now been supplemented by a new category of chronic infections caused by bacteria growing in slime-enclosed aggregates known as biofilms. Biofilm infections, such as pneumonia in cystic fibrosis patients, chronic wounds, chronic otitis media and implant- and catheter-associated infections, affect millions of people in the developed world each year and many deaths occur as a consequence. In general, bacteria have two life forms during growth and proliferation. In one form, the bacteria exist as single, independent cells (planktonic) whereas in the other form, bacteria are organized into sessile aggregates. The latter form is commonly referred to as the biofilm growth phenotype. Acute infections are assumed to involve planktonic bacteria, which are generally treatable with antibiotics, although successful treatment depends on accurate and fast diagnosis. However, in cases where the bacteria succeed in forming a biofilm within the human host, the infection often turns out to be untreatable and will develop into a chronic state. The important hallmarks of chronic biofilm-based infections are extreme resistance to antibiotics and many other conventional antimicrobial agents, and an extreme capacity for evading the host defences. In this thesis, I will assemble the current knowledge on biofilms with an emphasis on chronic infections, guidelines for diagnosis and treatment of these infections, before relating this to my previous research into the area of biofilms. I will present evidence to support a view that the biofilm lifestyle dominates chronic bacterial infections, where bacterial aggregation is the default mode, and that subsequent biofilm development progresses by adaptation to nutritional and environmental conditions. I will make a series of correlations to highlight the most important aspects of biofilms from my perspective, and to determine what can be deduced from the past decades of biofilm research. I will try to bridge in vitro and in vivo research and propose methods for studying biofilms based on this knowledge. I will compare how bacterial biofilms exist in stable ecological habitats and opportunistically in unstable ecological habitats, such as infections. Bacteria have a similar lifestyle (the biofilm) in both habitats, but the fight for survival and supremacy is different. On the basis of this comparison, I will hypothesize how chronic biofilm infections are initiated and how bacteria live together in these infections. Finally, I will discuss different aspects of biofilm infection diagnosis. Hopefully, this survey of current knowledge and my proposed guidelines will provide the basis and inspiration for more research, improved diagnostics, and treatments for well-known biofilm infections and any that may be identified in the future.
由致病细菌引起的急性感染已经被广泛研究了100多年。在过去的几个世纪里,这些感染夺走了数百万人的生命,但现代疫苗、抗生素和感染控制措施的发展有效地对抗了它们。大多数关于细菌致病机制的研究都集中在急性感染上,但现在这些疾病又出现了一类新的慢性感染,这类感染由生长在被称为生物膜的黏液包裹聚集体中的细菌引起。生物膜感染,如囊性纤维化患者的肺炎、慢性伤口、慢性中耳炎以及与植入物和导管相关的感染,每年在发达国家影响着数百万人,并导致许多人死亡。一般来说,细菌在生长和繁殖过程中有两种生命形式。一种形式是细菌以单个独立的细胞(浮游菌)存在,而另一种形式是细菌被组织成固着聚集体。后一种形式通常被称为生物膜生长表型。急性感染被认为涉及浮游菌,一般可用抗生素治疗,尽管成功治疗取决于准确快速的诊断。然而,在细菌成功在人类宿主体内形成生物膜的情况下,感染往往变得无法治疗,并会发展成慢性状态。基于慢性生物膜感染的重要特征是对抗生素和许多其他传统抗菌剂具有极强的耐药性,以及逃避宿主防御的极强能力。在本论文中,我将汇总关于生物膜的现有知识,重点是慢性感染、这些感染的诊断和治疗指南,然后将其与我之前在生物膜领域的研究联系起来。我将提供证据支持一种观点,即生物膜生活方式主导慢性细菌感染,其中细菌聚集是默认模式,随后生物膜的发展通过适应营养和环境条件而推进。我将进行一系列关联,从我的角度突出生物膜最重要的方面,并确定从过去几十年的生物膜研究中可以推断出什么。我将尝试弥合体外和体内研究的差距,并基于这些知识提出研究生物膜的方法。我将比较细菌生物膜在稳定生态栖息地和不稳定生态栖息地(如感染)中机会性存在的方式。细菌在这两种栖息地都有类似的生活方式(生物膜),但生存和占据主导地位的斗争有所不同。基于这种比较,我将假设慢性生物膜感染是如何开始的,以及细菌在这些感染中是如何共同生存的。最后,我将讨论生物膜感染诊断的不同方面。希望对现有知识的这次综述以及我提出的指南将为更多关于著名生物膜感染以及未来可能发现的任何生物膜感染的研究、改进诊断和治疗提供基础和灵感。